Cingulate Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Cingulate Inc. (Nasdaq: CING) on April 2, 2026, reporting events that occurred on March 27, 2026. The filing addresses corporate governance changes following stockholder approval of an Issuance Proposal.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel appointments and compensatory arrangements.
Material Changes
On March 27, 2026, Zhanpeng "Frederick" Jiang was appointed as a Class I member of the Board of Directors, effective immediately. His term extends until the 2028 Annual Meeting of Stockholders. Mr. Jiang was determined to be independent under Nasdaq Listing Rule 5605.
- Board Composition: The Class I directors now consist of Peter Werth, Jeff Hargroves, and Zhanpeng Jiang.
- Committee Appointments: Mr. Jiang was appointed to the Audit Committee, Compensation Committee, and Nominating and Corporate Governance Committee.
Compensatory Arrangements and Outlook
Under the Company's Non-Employee Director Compensation Program, Mr. Jiang received the following compensation:
- Stock Option: An option to purchase 15,000 shares of common stock. The exercise price equals the last reported sale price on the grant date. The option vests over one year in two equal installments on each six-month anniversary, contingent on continued board service.
- Cash Retainers:
- Board Service: $40,000 per year.
- Audit Committee: $7,500 per year.
- Compensation Committee: $5,000 per year.
- Nominating and Governance Committee: $4,000 per year.
The filing does not contain specific guidance, outlook, or risk factors beyond the standard contingencies related to the vesting of the stock option.
Investor Verification Checklist
- Verify the terms of the securities purchase agreement referenced in the January 28, 2026, Form 8-K.
- Confirm the exact exercise price of the 15,000 share option granted to Mr. Jiang based on the Nasdaq closing price on March 27, 2026.
- Review the updated composition of the Audit, Compensation, and Nominating committees for potential conflicts of interest.
- Monitor future filings for the vesting schedule execution of the granted stock option.